• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用改良的Martin/Hopkins估算方法或Friedewald公式计算的低密度脂蛋白胆固醇水平与直接匀相测定法测得的低密度脂蛋白胆固醇水平的比较。

Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol.

作者信息

Reiber Istvan, Mark Laszlo, Paragh Gyorgy, Toth Peter P

机构信息

Szent György University Teaching Hospital of Fejer County, Székesfehérvár, Hungary.

Bekes County Central Hospital Pándy Kálmán Branch, Cardiology, Gyula, Hungary.

出版信息

Arch Med Sci. 2020 Aug 3;18(3):577-586. doi: 10.5114/aoms.2020.97847. eCollection 2022.

DOI:10.5114/aoms.2020.97847
PMID:35591827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103614/
Abstract

INTRODUCTION

Low-density lipoprotein cholesterol (LDL-C) represents the primary lipoprotein target for reducing cardiovascular risk (CV). The aim of our study is to compare the direct and the calculated LDL-C levels in the range below 1.8 mmol/l and 2.6 mmol/l depending on triglycerides, and to evaluate the variation in remnant lipoprotein cholesterol.

MATERIAL AND METHODS

We investigated 14 906 lipid profiles from fasting blood samples of Hungarian individuals with triglycerides < 4.5 mmol/l. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and direct LDL-C were measured by the enzymatic assay. We calculated LDL-C by Friedewald's formula (F-LDL-C) and by using the new Martin/Hopkins estimation (MH-LDL-C).

RESULTS

For F-LDL-C below 1.8 mmol/l, MH-LDL-C was 58% between 1.8 and 2.59 mmol/l when TG was in the range 2.3-4.5 mmol/l. For F-LDL-C below 2.6 mmol/l, the MH-LDL-C concordance was 73% in the same TG range (2.3-4.5 mmol/l. If MH-LDL-C was less than 1.8 mmol/l or between 1.8 and 2.59 mmol/l, the difference between non-HDL-C (TC - HDL-C = AC: atherogenic cholesterol) and (MH)LDL-C was less than 0.8 mmol/l in the TG range below 2.3 mmol/l. The remnant lipoprotein cholesterol values were on average 0.5 mmol/l lower by the Martin/Hopkins estimation compared to the Friedewald's calculation if the TG was above 2.3 mmol/l.

CONCLUSIONS

The Friedewald equation tends to underestimate LDL-C levels in very high and high-risk settings. Our analysis supports the conclusion that in Hungarian patients, LDL-C estimation using the Martin/Hopkins formula, which is validated by the beta-quantification method, yields a more accurate LDL-C value than that calculated by the Friedewald formula.

摘要

引言

低密度脂蛋白胆固醇(LDL-C)是降低心血管风险(CV)的主要脂蛋白靶点。我们研究的目的是比较在甘油三酯水平不同情况下,1.8 mmol/l和2.6 mmol/l以下范围内直接测定的LDL-C水平与计算得出的LDL-C水平,并评估残余脂蛋白胆固醇的变化。

材料与方法

我们调查了14906例甘油三酯<4.5 mmol/l的匈牙利个体空腹血样的血脂谱。采用酶法测定总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)和直接LDL-C。我们通过Friedewald公式(F-LDL-C)和新的Martin/Hopkins估算方法(MH-LDL-C)计算LDL-C。

结果

对于F-LDL-C低于1.8 mmol/l的情况,当TG在2.3 - 4.5 mmol/l范围内时,MH-LDL-C在1.8至2.59 mmol/l之间的占比为58%。对于F-LDL-C低于2.6 mmol/l的情况,在相同TG范围(2.3 - 4.5 mmol/l)内,MH-LDL-C的一致性为73%。如果MH-LDL-C低于1.8 mmol/l或在1.8至2.59 mmol/l之间,在TG低于2.3 mmol/l的范围内,非HDL-C(TC - HDL-C = AC:致动脉粥样硬化胆固醇)与(MH)LDL-C之间的差异小于0.8 mmol/l。如果TG高于2.3 mmol/l,与Friedewald计算相比,采用Martin/Hopkins估算得出的残余脂蛋白胆固醇值平均低0.5 mmol/l。

结论

在极高和高风险情况下,Friedewald方程往往会低估LDL-C水平。我们的分析支持以下结论:在匈牙利患者中,使用经β定量法验证过的Martin/Hopkins公式估算LDL-C,比Friedewald公式计算得出的LDL-C值更准确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/991a7d4b1b5d/AMS-18-3-120306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/2021fb06926b/AMS-18-3-120306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/4747ba78e1d6/AMS-18-3-120306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/21f6ae4b982d/AMS-18-3-120306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/991a7d4b1b5d/AMS-18-3-120306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/2021fb06926b/AMS-18-3-120306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/4747ba78e1d6/AMS-18-3-120306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/21f6ae4b982d/AMS-18-3-120306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b726/9103614/991a7d4b1b5d/AMS-18-3-120306-g004.jpg

相似文献

1
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol.使用改良的Martin/Hopkins估算方法或Friedewald公式计算的低密度脂蛋白胆固醇水平与直接匀相测定法测得的低密度脂蛋白胆固醇水平的比较。
Arch Med Sci. 2020 Aug 3;18(3):577-586. doi: 10.5114/aoms.2020.97847. eCollection 2022.
2
Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation.非高密度脂蛋白胆固醇/甘油三酯比值比甘油三酯水平更能显著低估计算得出的低密度脂蛋白胆固醇(LDL-C):用于 LDL-C 估算的数学公式可靠性研究。
Clin Chem Lab Med. 2020 Dec 24;59(5):857-867. doi: 10.1515/cclm-2020-1366. Print 2021 Apr 27.
3
Validation of low-density lipoprotein cholesterol equations in pediatric population.验证低密度脂蛋白胆固醇方程在儿科人群中的适用性。
PeerJ. 2023 Jan 5;11:e14544. doi: 10.7717/peerj.14544. eCollection 2023.
4
Comparability of 11 different equations for estimating LDL cholesterol on different analysers.比较不同分析仪上 11 种不同 LDL 胆固醇估算方程的可比性。
Clin Chem Lab Med. 2021 Aug 12;59(12):1930-1943. doi: 10.1515/cclm-2021-0747. Print 2021 Nov 25.
5
Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.验证 Friedewald、Martin-Hopkins 和 Sampson 低密度脂蛋白胆固醇方程。
PLoS One. 2022 May 13;17(5):e0263860. doi: 10.1371/journal.pone.0263860. eCollection 2022.
6
A novel equation for the estimation of low-density lipoprotein cholesterol in the Saudi Arabian population: a derivation and validation study.沙特阿拉伯人群中低密度脂蛋白胆固醇估算的新方程:推导和验证研究。
Sci Rep. 2024 Mar 5;14(1):5478. doi: 10.1038/s41598-024-55921-w.
7
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.马丁/霍普金斯估计、弗里德瓦尔德估计和制备超速离心法评估低密度脂蛋白胆固醇的比较: FOURIER 试验的见解。
JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533.
8
[Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].[评估Friedewald公式计算血清低密度脂蛋白胆固醇浓度的精密度]
Pol Merkur Lekarski. 2001 Oct;11(64):348-51.
9
Comparison of measured LDL cholesterol with calculated LDL-cholesterol using the Friedewald and Martin-Hopkins formulae in diabetic adults at Charlotte Maxeke Johannesburg Academic Hospital/NHLS Laboratory.夏洛特·马克斯凯 Johannesburg 学术医院/NHLS 实验室糖尿病成人中使用 Friedewald 和 Martin-Hopkins 公式计算的 LDL 胆固醇与实测 LDL 胆固醇的比较。
PLoS One. 2022 Dec 14;17(12):e0277981. doi: 10.1371/journal.pone.0277981. eCollection 2022.
10
Impact of the Martin/Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population.马丁/霍普金斯改良 LDL-C 估测方程对高危患者人群血脂目标达标率的影响。
Clin Biochem. 2020 Feb;76:35-37. doi: 10.1016/j.clinbiochem.2019.12.002. Epub 2019 Dec 13.

引用本文的文献

1
Goal Achievement in 3017 Patients at Very High Cardiovascular Risk Based on Different LDL Cholesterol Calculations and Non-HDL Cholesterol Levels-Shortcomings of the Use of Non-HDL Cholesterol as a Target Depending on Triglyceride Levels.基于不同低密度脂蛋白胆固醇计算方法和非高密度脂蛋白胆固醇水平的3017例心血管极高风险患者的目标达成情况——根据甘油三酯水平将非高密度脂蛋白胆固醇用作目标的不足之处
J Clin Med. 2025 Jul 15;14(14):5003. doi: 10.3390/jcm14145003.
2
Lipoprotein(a) levels in a sample of 115,197 subjects from the largest Brazilian private laboratory.来自巴西最大的私立实验室的115197名受试者样本中的脂蛋白(a)水平。
PLoS One. 2025 Jun 27;20(6):e0326365. doi: 10.1371/journal.pone.0326365. eCollection 2025.
3

本文引用的文献

1
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会(PSLD)和波兰脂质协会(PoLA)2020年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2020 Mar 2;16(2):237-252. doi: 10.5114/aoms.2020.93253. eCollection 2020.
2
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.高甘油三酯血症弗雷德里克森-利维及李斯血脂异常表型患者的脂蛋白谱特征:脂质研究大型数据库6和7
Arch Med Sci. 2019 Sep;15(5):1195-1202. doi: 10.5114/aoms.2019.87207. Epub 2019 Aug 22.
3
Assessing Performance of Martins's and Sampson's Formulae for Calculation of LDL-C in Indian Population: A Single Center Retrospective Study.
评估马丁斯公式和桑普森公式在印度人群中计算低密度脂蛋白胆固醇(LDL-C)的性能:一项单中心回顾性研究。
Indian J Clin Biochem. 2024 Oct;39(4):579-585. doi: 10.1007/s12291-023-01142-3. Epub 2023 Jul 7.
4
The Evaluation of Lipid-Lowering Treatment in Patients with Acute Coronary Syndrome in a Hungarian Invasive Centre in 2015, 2017, and during the COVID-19 Pandemic-The Comparison of the Achieved LDL-Cholesterol Values Calculated with Friedewald and Martin-Hopkins Methods.2015年、2017年及新冠疫情期间匈牙利一家介入治疗中心急性冠状动脉综合征患者降脂治疗的评估——Friedewald法与Martin-Hopkins法计算的低密度脂蛋白胆固醇达标值比较
J Clin Med. 2024 Jun 11;13(12):3398. doi: 10.3390/jcm13123398.
5
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?2023年:心血管疾病之年——新型及前瞻性降脂疗法之年。到2024年我们能让血脂异常成为罕见病吗?
Arch Med Sci. 2023 Nov 2;19(6):1602-1615. doi: 10.5114/aoms/174743. eCollection 2023.
6
Assessing the Practical Differences in LDL-C Estimates Calculated by Friedewald, Martin/Hopkins, or NIH Equation 2: An Observation Cross-Sectional Study.评估通过弗里德瓦尔德、马丁/霍普金斯或美国国立卫生研究院方程2计算的低密度脂蛋白胆固醇(LDL-C)估计值的实际差异:一项横断面观察研究。
J Lipid Atheroscler. 2023 Sep;12(3):252-266. doi: 10.12997/jla.2023.12.3.252. Epub 2023 Jun 20.
7
Comparison of measured LDL cholesterol with calculated LDL-cholesterol using the Friedewald and Martin-Hopkins formulae in diabetic adults at Charlotte Maxeke Johannesburg Academic Hospital/NHLS Laboratory.夏洛特·马克斯凯 Johannesburg 学术医院/NHLS 实验室糖尿病成人中使用 Friedewald 和 Martin-Hopkins 公式计算的 LDL 胆固醇与实测 LDL 胆固醇的比较。
PLoS One. 2022 Dec 14;17(12):e0277981. doi: 10.1371/journal.pone.0277981. eCollection 2022.
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.
比较脂蛋白胆固醇残留的不同评估方法:非常大的脂质数据库。
J Clin Lipidol. 2019 Jul-Aug;13(4):634-644. doi: 10.1016/j.jacl.2019.06.001. Epub 2019 Jun 11.
4
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.低密度脂蛋白胆固醇极低浓度、高敏 C 反应蛋白与 Reasons for Geographical and Racial Differences in Stroke(REGARDS)研究中健康结局的相关性。
Eur Heart J. 2018 Oct 21;39(40):3641-3653. doi: 10.1093/eurheartj/ehy533.
5
Practice setting and secondary prevention of coronary artery disease.冠心病的实践环境与二级预防
Arch Med Sci. 2018 Aug;14(5):979-987. doi: 10.5114/aoms.2017.65236. Epub 2017 Jan 19.
6
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.马丁/霍普金斯估计、弗里德瓦尔德估计和制备超速离心法评估低密度脂蛋白胆固醇的比较: FOURIER 试验的见解。
JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533.
7
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.量化动脉粥样硬化脂蛋白:个体化医学和极低 LDL 胆固醇浓度时代的当前和未来挑战。EAS 和 EFLM 的共识声明。
Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14.
8
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.新型低密度脂蛋白胆固醇评估对特定全球血脂异常指南中次要非高密度脂蛋白胆固醇和载脂蛋白 B 目标的适用性的影响。
Circulation. 2018 Jul 17;138(3):244-254. doi: 10.1161/CIRCULATIONAHA.117.032463. Epub 2018 Mar 5.
9
Hypercholesterolaemia - practical information for non-specialists.高胆固醇血症——非专科医生实用信息
Arch Med Sci. 2018 Jan;14(1):1-21. doi: 10.5114/aoms.2018.72238. Epub 2017 Dec 19.
10
Update on the laboratory investigation of dyslipidemias.血脂异常的实验室检查进展。
Clin Chim Acta. 2018 Apr;479:103-125. doi: 10.1016/j.cca.2018.01.015. Epub 2018 Jan 11.